← Leaderboards
James H. Segars
Child Health And Human Development
$10,363,677
Attributed
$26,115,570
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.2M · FY2019–25$10M$7.5M$5M$2.5M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,115,570 · 6
By mechanism
R01$17,443,559 · 5
U01$8,672,011 · 1
Top collaborators
- Valerie Lynn Baker11 shared
- Xiaoqin Wang6 shared
- Richard L Huganir5 shared
- Christopher A Ross5 shared
- Ie-Ming Shih5 shared
- Mostafa A. Borahay3 shared
- Jennifer Hartt Elisseeff3 shared
- Shuo Xiao2 shared
Most similar at Child Health And Human Development
Same institution · by research overlap
Others in their field
Other Emerging Leaders on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Abraham Aizer Brody · New York University School Of Medicine$16,015,961
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,031,836
- Michael P Harms · Washington University$13,645,932
- Jorge Eduardo Chavarro · Harvard School Of Public Health$12,830,103
Research focus
WomanInfertilityEndometrialPhenotypeResponseAffectResearch PersonnelCellsUterine FibroidsPregnancyTissuesFibroid TumorEndometriosisGenesFutureFertilization In VitroEndometriumCaringEmbryo TransferReproductiveDiagnosisHealth DisparityEmbryoMenstruation
Grant awards (38)
Tools for gene editing in marmosets$2,165,656
U01 · FY2025 · DA
Role of senescent cells in uterine fibroid pathogenesis$791,630
R01 · FY2025 · HD · contact PI
Mechanisms of uterine fluid absorption during early pregnancy$648,318
R01 · FY2025 · HD
Tools for gene editing in marmosets$1,955,019
U01 · FY2024 · DA
Role of senescent cells in uterine fibroid pathogenesis$803,402
R01 · FY2024 · HD · contact PI
Mechanisms of uterine fluid absorption during early pregnancy$685,199
R01 · FY2024 · HD
Tools for gene editing in marmosets$393,778
U01 · FY2024 · DA
Tools for gene editing in marmosets$2,195,576
U01 · FY2023 · DA
1/3 A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)$1,203,789
R01 · FY2023 · HD
1/3 A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)$950,730
R01 · FY2023 · HD
Role of senescent cells in uterine fibroid pathogenesis$818,748
R01 · FY2023 · HD · contact PI
Role of cancer-associated mutations in endometriosis$660,893
R01 · FY2023 · HD · contact PI
1/4 Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids$207,216
R01 · FY2023 · HD · contact PI
Tools for gene editing in marmosets$163,748
U01 · FY2023 · DA
1/3 A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)$2,025,457
R01 · FY2022 · HD
Tools for gene editing in marmosets$1,798,234
U01 · FY2022 · DA
Role of cancer-associated mutations in endometriosis$669,600
R01 · FY2022 · HD · contact PI
1/4 Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids$189,601
R01 · FY2022 · HD · contact PI
1/3 A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)$2,017,129
R01 · FY2021 · HD
Role of cancer-associated mutations in endometriosis$674,852
R01 · FY2021 · HD · contact PI
1/4 Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids$191,602
R01 · FY2021 · HD · contact PI
1/3 A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)$2,067,564
R01 · FY2020 · HD
Role of cancer-associated mutations in endometriosis$698,200
R01 · FY2020 · HD · contact PI
1/4 Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids$197,184
R01 · FY2020 · HD · contact PI
1/3 A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro)$1,000,002
R01 · FY2019 · HD
Role of cancer-associated mutations in endometriosis$739,745
R01 · FY2019 · HD · contact PI
1/4 Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids$202,698
R01 · FY2019 · HD · contact PI
Reproductive Endocrinology And Infertility Clinical Training Program$805,143
ZIE · FY2014 · HD · contact PI
Reproductive Endocrinology And Infertility Clinical Training Program$1,048,450
ZIE · FY2013 · HD · contact PI
Reproductive Endocrinology And Infertility Clinical Training Program$798,933
ZIE · FY2012 · HD · contact PI
Reproductive Endocrinology And Infertility Clinical Training Program$2,135,324
ZIE · FY2011 · HD · contact PI
Reproductive Endocrinology And Infertility Clinical Training Program$1,822,588
ZIA · FY2010 · HD · contact PI
Reproductive Endocrinology And Infertility Clinical Training Program$1,394,904
ZIA · FY2009 · HD · contact PI
Reproductive Endocrinology And Infertility Clinical Training Program$2,018,370
Z01 · FY2008 · HD · contact PI
Reproductive Endocrinology And Infertility Clinical Training Program$643,120
Z01 · FY2007 · HD · contact PI
Reproductive Endocrinology And Infertility Clinical Trai$0
Z01 · FY2006 · HD · contact PI
Reproductive Endocrinology And Infertility Clinical Trai$0
Z01 · FY2005 · HD
Reproductive Endocrinology And Infertility Clinical*$0
Z01 · FY2004 · HD